Armand Bensussan studied at Paris Diderot University and at Pasteur Institute, Paris, France. He completed his Ph.D. degree training during the early 1980s at the laboratories of Professor J. Dausset, Saint Louis Hospital, Paris, France and Professor S. F. Schlossman, Harvard Medical School, DFCI, Boston, Mass, USA. He did his entire scientific carrier at the French National Institute of Health and Medical Research (INSERM). He is currently the Director of Research and Chief of the Skin Research Center and of the INSERM unit 976 at Saint-Louis Hospital in Paris. He obtained several French awards including two distinct French Academy of Sciences awards, the Clinical Investigation Award from the French Foundation for Medical Research, the Immunology Bernard Halpern Award, and the national award of projects leaders for the creation and/or development of highly innovative technology companies. He was the Former President of the French Society of Immunology. He is the cofounder of the biotechnology company Orega Biotech. His main scientific contributions have been in the field of basic and clinical immunology and in tumor dermatology. He described and studied the structure and function of several receptors such as CD160/BY55 and CD100/Semaphorin 4D. He identified several NK receptors expressed by the cutaneous malignant CD4+ T lymphomas and studied their function and their potential role in the pathophysiology of the disease. He is the author of 250 international scientific publications and editor of two scientific books. He is an editorial board member of different international scientific journals and a Member of the Human Cell Differentiation Molecules Council.
Biography Updated on 18 September 2012